‌

US Patent 11547761 Antibody adjuvant conjugates

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Shelley Erin Ackerman0

Edgar George Engleman0

Justin Kenkel0

Michael Nathaniel Alonso0

Arthur Lee0

David Y. Jackson0

Date of Patent

January 10, 2023

0

Patent Application Number

174668730

Date Filed

September 3, 2021

0

Patent Citations

US Patent 10208037 Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds

US Patent 10722591 Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof

US Patent 10744204 Conjugated compounds comprising cysteine-engineered antibodies

US Patent 10744206 Compounds and compositions for immunotherapy

US Patent 10780180 Compounds and compositions for immunotherapy

US Patent 10849984 Immunogenic compound

US Patent 10953073 XTEN conjugate compositions and methods of making same

US Patent 10973826 Antibody conjugates comprising toll-like receptor agonist

...

Patent Primary Examiner

0

The invention provides an immunoconjugate comprising an antibody construct which includes an antigen binding domain and an Fc domain, an adjuvant moiety, and a linker, wherein each adjuvant moiety is covalently bonded to the antibody via the linker. Methods for treating cancer with the immunoconjugates of the invention are also described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11547761 Antibody adjuvant conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.